1. Home
  2. SONN vs ICU Comparison

SONN vs ICU Comparison

Compare SONN & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • ICU
  • Stock Information
  • Founded
  • SONN N/A
  • ICU 2018
  • Country
  • SONN United States
  • ICU United States
  • Employees
  • SONN N/A
  • ICU N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • ICU Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONN Health Care
  • ICU Health Care
  • Exchange
  • SONN Nasdaq
  • ICU Nasdaq
  • Market Cap
  • SONN 21.4M
  • ICU 25.6M
  • IPO Year
  • SONN N/A
  • ICU N/A
  • Fundamental
  • Price
  • SONN $2.85
  • ICU $0.79
  • Analyst Decision
  • SONN Strong Buy
  • ICU
  • Analyst Count
  • SONN 1
  • ICU 0
  • Target Price
  • SONN $20.00
  • ICU N/A
  • AVG Volume (30 Days)
  • SONN 563.6K
  • ICU 1.4M
  • Earning Date
  • SONN 08-13-2025
  • ICU 08-13-2025
  • Dividend Yield
  • SONN N/A
  • ICU N/A
  • EPS Growth
  • SONN N/A
  • ICU N/A
  • EPS
  • SONN N/A
  • ICU N/A
  • Revenue
  • SONN $1,000,000.00
  • ICU $766,000.00
  • Revenue This Year
  • SONN $5,376.22
  • ICU $894.81
  • Revenue Next Year
  • SONN N/A
  • ICU $71.78
  • P/E Ratio
  • SONN N/A
  • ICU N/A
  • Revenue Growth
  • SONN 1689.52
  • ICU N/A
  • 52 Week Low
  • SONN $1.08
  • ICU $0.31
  • 52 Week High
  • SONN $19.30
  • ICU $5.79
  • Technical
  • Relative Strength Index (RSI)
  • SONN 39.92
  • ICU 48.18
  • Support Level
  • SONN $3.02
  • ICU $0.81
  • Resistance Level
  • SONN $3.80
  • ICU $0.92
  • Average True Range (ATR)
  • SONN 0.31
  • ICU 0.07
  • MACD
  • SONN -0.04
  • ICU -0.00
  • Stochastic Oscillator
  • SONN 10.26
  • ICU 20.11

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: